AU9635998A - Solid dispersing vaccine composition for oral delivery - Google Patents

Solid dispersing vaccine composition for oral delivery

Info

Publication number
AU9635998A
AU9635998A AU96359/98A AU9635998A AU9635998A AU 9635998 A AU9635998 A AU 9635998A AU 96359/98 A AU96359/98 A AU 96359/98A AU 9635998 A AU9635998 A AU 9635998A AU 9635998 A AU9635998 A AU 9635998A
Authority
AU
Australia
Prior art keywords
vaccine composition
oral delivery
solid dispersing
adjuvant
mucosal tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU96359/98A
Other languages
English (en)
Inventor
Harry Seager
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Catalent Pharma Solutions Inc
Original Assignee
Catalent Pharma Solutions Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Catalent Pharma Solutions Inc filed Critical Catalent Pharma Solutions Inc
Publication of AU9635998A publication Critical patent/AU9635998A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Formation And Processing Of Food Products (AREA)
AU96359/98A 1997-10-27 1998-10-27 Solid dispersing vaccine composition for oral delivery Abandoned AU9635998A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9722682.3A GB9722682D0 (en) 1997-10-27 1997-10-27 Pharmaceutical products
GB9722682 1997-10-27
PCT/GB1998/003209 WO1999021579A1 (en) 1997-10-27 1998-10-27 Solid dispersing vaccine composition for oral delivery

Publications (1)

Publication Number Publication Date
AU9635998A true AU9635998A (en) 1999-05-17

Family

ID=10821162

Family Applications (1)

Application Number Title Priority Date Filing Date
AU96359/98A Abandoned AU9635998A (en) 1997-10-27 1998-10-27 Solid dispersing vaccine composition for oral delivery

Country Status (10)

Country Link
EP (1) EP1024824B1 (enExample)
JP (1) JP2001521007A (enExample)
AT (1) ATE274919T1 (enExample)
AU (1) AU9635998A (enExample)
DE (1) DE69826019T2 (enExample)
DK (1) DK1024824T3 (enExample)
ES (1) ES2227885T3 (enExample)
GB (1) GB9722682D0 (enExample)
PT (1) PT1024824E (enExample)
WO (1) WO1999021579A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6592869B2 (en) * 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
IL148247A0 (en) 1999-08-24 2002-09-12 Teva Pharma A vaccine composition and method of using the same
GB0020089D0 (en) * 2000-08-15 2000-10-04 Smithkline Beecham Biolog Vaccine Composition
DE10125731A1 (de) * 2001-05-17 2003-03-06 A I D Autoimmun Diagnostika Gm Darreichungsform von immunologischen Wirkstoffen
WO2004047793A1 (en) 2002-11-26 2004-06-10 Alk-Abelló A/S Pharmaceutical allergen product
CA2516291C (en) * 2003-02-28 2012-02-14 Alk-Abello A/S Dosage form having a saccharide matrix
US8012505B2 (en) 2003-02-28 2011-09-06 Alk-Abello A/S Dosage form having a saccharide matrix
US20060172005A1 (en) * 2003-07-10 2006-08-03 Kyowa Hakko Kogyo Co.,Ltd. Tablet and process for producing the same
DE20321887U1 (de) 2003-11-10 2012-01-20 Allergan, Inc. Arzneimittel umfassend niedrige Dosierungen von Desmopressin
AU2003287591C1 (en) 2003-11-10 2009-12-10 Serenity Pharmaceuticals Llc Pharmaceutical compositions including low dosages of desmopressin
US20060210590A1 (en) 2005-02-03 2006-09-21 Alk-Abello A/S Minor allergen control to increase safety of immunotherapy
AU2006299310A1 (en) 2005-10-04 2007-04-12 Alk-Abello A/S Solid vaccine formulation
EP2187926B1 (en) 2007-09-11 2012-01-25 Københavns Universitet Prevention of diabetes by administration of gliadin
EP2163239A1 (de) * 2008-05-27 2010-03-17 Qiagen GmbH Produkte, die Biopartikel enthalten, Verfahren zu ihrer Herstellung
CA2767673A1 (en) * 2009-07-17 2011-01-20 The Board Of Regents Of Oklahoma State University Supralingual vaccines and applicators
GB201009273D0 (en) * 2010-06-03 2010-07-21 Glaxosmithkline Biolog Sa Novel vaccine
JP6061859B2 (ja) * 2010-10-08 2017-01-18 アール．ピー． シェーラー テクノロジーズ エルエルシー デンプンを使用する経口ワクチン速溶性剤型
EP2952200A1 (en) 2014-06-04 2015-12-09 Alk-Abelló A/S Allergen for prophylactic treatment of allergy
TWI745278B (zh) 2014-10-10 2021-11-11 以色列商艾畢克生物實驗有限公司 發泡性降低之疫苗組合物
US11523988B2 (en) * 2018-11-29 2022-12-13 Catalent U.K. Swindon Zydis Limited Oral dispersible vaccine comprising virosomes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
IE45770B1 (en) * 1976-10-06 1982-11-17 Wyeth John & Brother Ltd Pharmaceutical dosage forms
US5298261A (en) * 1992-04-20 1994-03-29 Oregon Freeze Dry, Inc. Rapidly distintegrating tablet
WO1994020070A1 (en) * 1993-03-11 1994-09-15 Secretech, Inc. Polymeric mucoadhesives in the delivery of immunogens at mucosal surfaces
US5709861A (en) * 1993-04-22 1998-01-20 Emisphere Technologies, Inc. Compositions for the delivery of antigens
GB9514285D0 (en) * 1995-07-13 1995-09-13 Univ Nottingham Polymeric lamellar substrate particles for drug delivery

Also Published As

Publication number Publication date
DE69826019T2 (de) 2005-09-15
ATE274919T1 (de) 2004-09-15
DE69826019D1 (de) 2004-10-07
EP1024824A1 (en) 2000-08-09
EP1024824B1 (en) 2004-09-01
WO1999021579A1 (en) 1999-05-06
PT1024824E (pt) 2004-11-30
DK1024824T3 (da) 2004-09-20
GB9722682D0 (en) 1997-12-24
JP2001521007A (ja) 2001-11-06
ES2227885T3 (es) 2005-04-01

Similar Documents

Publication Publication Date Title
AU9635998A (en) Solid dispersing vaccine composition for oral delivery
GB0025577D0 (en) Vaccine
WO2000062800A3 (en) Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
EP1404363A4 (en) ADJUVANT COMPOSITION FOR MUCUSAL OR INJECTION VACCINES
EP1733735A3 (en) Methods and products for inducing mucosal immunity
AU4673099A (en) Use of bioadhesives and adjuvants for the mucosal delivery of antigens
LU91327I2 (fr) Vaccin papillomavirus humain Ätypes 56,11,16,18Ü(recombinant, adsorbé)
AP9801392A0 (en) Concentrated antibody preparation.
AU2238597A (en) Iscom or iscom-matrix comprising a mucus targetting substance and optionally, an antigen
NZ287385A (en) Antigenic preparation comprising the catalase of helicobacter bacteria and vaccines used to treat helicobacter infection
WO2001097841A3 (en) Qs-21 and il-12 as an adjuvant combination
AU3853495A (en) Immunogenic compositions
AU1987197A (en) Gene delivery to mucosal epithelium for immunization or therapeutic purpose
AU2015095A (en) Mucosal administration of pneumococcal antigens
MY127452A (en) Vaccines.
AU4450696A (en) Enhanced immunogenic vaccine
HUP0400495A3 (en) Oral mucosal dosage forms of apomorphine, suitable for the administration via oral mucosal tissue
AU561683B2 (en) Combined influenza, diphtheria, tetanus vaccine
GB9711032D0 (en) Compound as a stimulant for the central nervous system
NZ332690A (en) Stimulation of host defence mechanisms against viral challenges using interferon
AU6576400A (en) Inactivated vaccine against feline calicivirus disease
AU1399100A (en) Therapeutic treatment with immunogenic drugs
AU4258297A (en) Papillomavirus vaccine formulation
AU2003294192A8 (en) Inclusion bodies as antigens for the oral vaccination of animals
HK1057694A (en) Oral solid dose vaccine

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase